Shennon Biotechnologies Inc.
An antibody development scientist at a biotech startup works on a proprietary single-cell platform for immunotherapy. The role involves designing and optimizing T-cell engagers, collaborating with cross-functional teams, and contributing to drug candidate development.
Headquarters
San Francisco, California, United States
Company Size
11-50 employees
Founded
2021
Shennon Bio is a biotech company that uses a proprietary ultra‑high‑throughput single‑cell platform to functionally profile and manipulate millions of immune cells for target discovery. By identifying rare, hard‑to‑find cellular targets, the company develops more precise immunotherapies and is initially advancing T‑cell engagers for solid tumors and autoimmune diseases. Shennon pairs this technology with an interdisciplinary, people‑centered culture focused on collaboration, ownership, and translating cellular insights into next‑generation treatments.
Shennon Biotechnologies Raises $13M Seed Financing to Accelerate Immunotherapy Target Discovery with Proprietary Single-Cell Functional Screening Platform
Mar 13, 2023
How a onetime VC came back to science to focus on finding better targets faster against cancer
Mar 15, 2023
SVB’s failure was contained. Its effects on biotech could still linger.
Mar 14, 2023
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Shennon Biotechnologies Inc..
Right around the average for this role
In Early-Phase Pancreatic Cancer Clinical Trial, Investigational mRNA Vaccine Induces Sustained Immune Activity in Small Patient Group
Feb 19, 2025
Research (or Senior) Scientist - Antibody Discovery & Optimization
City of Pierre, South Dakota
Research (or Senior) Scientist - Antibody Discovery & Optimization
City of Winnipeg
R&D - Intrepide-Principal Scientist I, Biologics Discovery & Innovation - SZ
sanofi us
Antibody Discovery Scientist
GSK plc
Senior Scientist, Antibody Engineering & Discovery (BMD)
Pfizer
Director of Antibody Discovery
bighatbiosciences